GlucoTrack, Inc.
GCTK
$0.1714
-$0.0026-1.49%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Revenue | -- | -- | -- | -- | -- |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | -- | -- | -- | -- | -- |
| Cost of Revenue | -- | -- | -- | -- | -- |
| Gross Profit | -- | -- | -- | -- | -- |
| SG&A Expenses | 110.33% | 48.67% | 23.14% | 3.85% | -2.32% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 104.77% | 119.45% | 158.24% | 89.73% | 60.29% |
| Operating Income | -104.77% | -119.45% | -158.24% | -89.73% | -60.29% |
| Income Before Tax | -218.40% | -149.75% | -157.67% | -88.81% | -60.02% |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -218.40% | -149.75% | -157.67% | -88.81% | -60.02% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | -218.40% | -149.75% | -157.67% | -88.81% | -60.02% |
| EBIT | -104.77% | -119.45% | -158.24% | -89.73% | -60.29% |
| EBITDA | -104.96% | -119.95% | -158.50% | -89.98% | -60.58% |
| EPS Basic | -73.64% | -59.16% | -50.89% | -38.34% | -32.28% |
| Normalized Basic EPS | -55.86% | -79.05% | -72.22% | -25.07% | -18.44% |
| EPS Diluted | -73.64% | -59.16% | -50.89% | -38.34% | -32.28% |
| Normalized Diluted EPS | -55.86% | -79.05% | -72.22% | -25.07% | -18.44% |
| Average Basic Shares Outstanding | 59.14% | 36.72% | 44.44% | 49.25% | 34.06% |
| Average Diluted Shares Outstanding | 59.14% | 36.72% | 44.44% | 49.25% | 34.06% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |